CM

Chander Mohan

Active Director Director DIN 06834176
DIN 06834176 First appointment May 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 3 historical roles
Total affiliations 6 Since May 2014
Shareholding value •••• Premium profile

About Chander Mohan

Data last updated:

Chander Mohan is a Director at Cubic Lifesciences Private Limited (since 2014), Director at Everwell Pharma Private Limited (since 2014) and Director at Promo Pharma Private Limited (since 2022). The companies operate in Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹15.50 Cr; the largest is Cubic Lifesciences Private Limited at ₹7.59 Cr (FY 2025). Earlier, Chander Mohan was a Director at Alzey Pharmaceuticals Private Limited (2022–2024) and Director at Medevac Lifesciences Private Limited (2016–2017) and 1 more.

DIN 06834176
Primary Designation Director
Industry Pharma
First Appointment 09 May 2014
Oldest Company Age 12 yrs
Largest company Cubic Lifesciences Private Limited · ₹7.59 Cr (FY 2025)
Combined revenue ₹15.50 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cubic Lifesciences Private Limited U51397CH2014PTC035059
Director09 May 20142014₹7.59 Cr (FY 2025)Active
Everwell Pharma Private Limited U51900CH2014PTC035248
Director17 Oct 20142014₹7.16 Cr (FY 2024)Active
Promo Pharma Private Limited U51909HR2022PTC104312
Director13 Jun 20222022₹74.8 Lakh (FY 2023)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Apr 20222020₹5.56 Cr (FY 2025)Active
Medevac Lifesciences Private Limited U51909HP2016PTC006354
Director16 Sep 20162016₹2.00 Cr (FY 2025)Active
Cubiwell Healthcare Private Limited U51397CH2019PTC042470
Director25 Apr 20192019₹1.36 Cr (FY 2022)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Chander Mohan

Directorship timeline

Open interactive timeline →
Cubic Lifesciences Private Limited
Everwell Pharma Private Limited
Promo Pharma Private Limited
Alzey Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Chander Mohan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chander Mohan

Chander Mohan currently holds 3 directorships: Cubic Lifesciences Private Limited (Director, since 09 May 2014, revenue ₹7.59 Cr (FY 2025)); Everwell Pharma Private Limited (Director, since 17 Oct 2014, revenue ₹7.16 Cr (FY 2024)); Promo Pharma Private Limited (Director, since 13 Jun 2022, revenue ₹74.8 Lakh (FY 2023)).

Chander Mohan was first appointed on 09 May 2014 as Director at Cubic Lifesciences Private Limited. The most recent appointment on record is 13 Jun 2022 at Promo Pharma Private Limited.

The 3 current companies of Chander Mohan that report revenue have a combined latest revenue of ₹15.50 Cr: Cubic Lifesciences Private Limited ₹7.59 Cr (FY 2025); Everwell Pharma Private Limited ₹7.16 Cr (FY 2024); Promo Pharma Private Limited ₹74.8 Lakh (FY 2023).

Chander Mohan held 3 earlier board appointments: Alzey Pharmaceuticals Private Limited (Director, 09 Apr 2022 to 10 Jan 2024); Medevac Lifesciences Private Limited (Director, 16 Sep 2016 to 19 Jun 2017); Cubiwell Healthcare Private Limited (Director, 25 Apr 2019 to 10 Dec 2019).

The current boards of Chander Mohan's companies include Swati Bhalla (Cubic Lifesciences Private Limited), Manish Bhalla (Everwell Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available